An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Interstitial Cystitis, Painful Bladder Syndrome

In brief

The purpose of this study is to determine whether PD 0299685 is effective in the treatment of symptoms associated with interstitial cystitis/painful bladder syndrome, such as pain, urinary urgency and frequency. At the same time assess the drug's safety and tolerability.

Key facts

Study ID

NCT00739739

Run by

Pfizer

People needed

161

Starts

2008-08-01

Expected to finish

2010-01-01

Last updated by the study team

2011-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women over 18 years of age with moderate to severe interstitial cystitis defined by pain score.
• Women must not be pregnant or lactating, They may be post-menopausal, surgically sterilized or using an appropriate method of contraception.

You may not qualify if…

• History of interstitial cystitis less than 6 months
• History of current or recurrent urinary tract infections, or genitourinary cancer
• Any previous urinary diversion procedure with or without bladder removal, bladder augmentation
• Use of certain drugs given into the bladder up to 1 month prior to study entry

Where it is running

• Pfizer Investigational Site — Mobile, Alabama, United States
• Pfizer Investigational Site — Goodyear, Arizona, United States
• Pfizer Investigational Site — Litchfield Park, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Glendora, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Farmington, Connecticut, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Jeffersonville, Indiana, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Brighton, Massachusetts, United States
• Pfizer Investigational Site — Watertown, Massachusetts, United States
• Pfizer Investigational Site — Garden City, New York, United States
• Pfizer Investigational Site — Poughkeepsie, New York, United States
• Pfizer Investigational Site — Burlington, North Carolina, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — West Chester, Ohio, United States
• Pfizer Investigational Site — Bethany, Oklahoma, United States
• Pfizer Investigational Site — State College, Pennsylvania, United States
• Pfizer Investigational Site — Charleston, South Carolina, United States
• Pfizer Investigational Site — Mt. Pleasant, South Carolina, United States
• Pfizer Investigational Site — Nashville, Tennessee, United States
• Pfizer Investigational Site — Spokane, Washington, United States
• Pfizer Investigational Site — Victoria, British Columbia, Canada
• Pfizer Investigational Site — Barrie, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.